controversy about whether naproxen is safer in patients with heart disease than other NSAIDs

You'll hear controversy about whether naproxen is safer in patients with heart disease than other NSAIDs.

All NSAIDs have a warning about increased CV risk. This was added almost a decade ago after the withdrawal of rofecoxib (Vioxx).

But CV risk isn't necessarily equal among NSAIDs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote